Gene ID ▲ | Gene Name | Gene Symbol | Disease Ontology |
---|---|---|---|
104935094 | ALG3 alpha-1,3- mannosyltransferase |
|
|
104935259 | glycogenin 1a |
|
|
104935271 | Carbohydrate sulfotransferase 1-like |
|
|
104935354 | UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 16 |
|
|
104935378 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase 3 |
|
|
104935626 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4 |
|
|
104935810 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 5 |
|
|
104935881 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
|
|
104935952 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
|
|
104936152 | carbohydrate sulfotransferase 12 |
|
|
104936167 | core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase 1a |
|
|
104936231 | ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase |
|
|
104936372 | fucosyltransferase 7 (alpha (1,3) fucosyltransferase) |
|
|
104936383 | UDP-glucose ceramide glucosyltransferase |
|
|
104936574 | exostosin-like glycosyltransferase 2 |
|
|
104936725 | fukutin |
|
|
104936733 | beta-1,3-galactosyltransferase 5-like |
|
|
104937002 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
|
|
104937003 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase 1 |
|
|
104937142 | exostosin glycosyltransferase 1b |
|
|
104937198 | glycogenin 1b |
|
|
104937299 | carbohydrate (N-acetylglucosamine-6-O) sulfotransferase 2b |
|
|
104937332 | mannose-P-dolichol utilization defect 1 protein |
|
|
104937434 | chondroitin sulfate synthase 3 |
|
|
104937494 | protein O-glucosyltransferase 1 |
|
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024